Why the study?
Splenic infarction is an uncommon thromboembolic condition associated with AF that presents with nonspecific abdominal manifestations, leading to diagnostic challenges.
Does timely initiation of therapeutic anticoagulation (enoxaparin followed by rivaroxaban) resolve symptoms and prevent recurrent embolic events in a patient with persistent atrial fibrillation presenting with acute cardioembolic splenic infarction?
Case Report (n=1)
No
Does timely initiation of therapeutic anticoagulation (enoxaparin followed by rivaroxaban) resolve symptoms and prevent recurrent embolic events in a patient with persistent atrial fibrillation presenting with acute cardioembolic splenic infarction?
In patients with persistent atrial fibrillation and inadequate anticoagulation presenting with acute left upper quadrant pain, contrast-enhanced CT is essential to diagnose splenic infarction—even when initial non-contrast CT is normal—and timely initiation of therapeutic anticoagulation can lead to rapid symptom resolution.
Supports anticoagulation for AF-related splenic infarction in select cases; leaves open confirmation in prospective trials.
BACKGROUND Splenic infarction is an uncommon thromboembolic condition associated with atrial fibrillation (AF) but with nonspecific abdominal manifestations, leading to diagnostic challenges. CASE SUMMARY A 56-year-old male with persistent AF and inadequate anticoagulation management presented with acute left upper quadrant pain without cardiac symptoms. Contrast-enhanced computed tomography was performed and revealed a characteristic wedge-shaped splenic infarction. Following therapeutic anticoagulation, the patient's symptoms rapidly resolved. CONCLUSION Acute left upper quadrant pain in patients with AF should raise a clinical suspicion of splenic infarction. The early initiation of therapeutic anticoagulation when cardioembolic etiology is suspected and contraindications are absent may contribute to a favorable outcome and reduce the risk of recurrent embolic events.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2026) conducted a case report in Splenic infarction associated with persistent atrial fibrillation (n=1). Enoxaparin followed by Rivaroxaban was evaluated on Symptom resolution and clinical stability.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: